Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Anyone know the pricing of the Icanthera IPO, some guessing but perhaps 20million shares to be issued (35% of 60mm in issue on IPO doc) to raise £2-3mm new cash, implies a new market cap of between £6-9mm, meaning Immupharma 14% stake (now diluted to 11%) would be worth £700k-£1.1mm) ie most likely less than when Tim used (invested) Immupharma’s much needed cash resources in this new sideline. I see Tim picks up 5.9% personally post IPO, having not have an interest Pre IPO. Nice work if you can get it. IMM retains their ATM warrants, which could of course be worthwhile if Icanthera succeeds, provides us with two 3 legged horses to back, I suppose 6 legs may turn out to be better than 4 legs, we can continue to live in hope. Good luck all, not investment advice, Joe
Kalan - apologies, if you were replying to Shangrila then yes, 0.53 could have been within the spread and miss reported Sell vs Buy. I was referring to the much larger trade volumes to which EyesBlue was assessing. We will all find out in time.
Kalan, I get the spread, it was not the spread... the transaction was a slightly different amount and executed at the offer, it was simply not printed at all... it would have appeared as a buy. No matter I can make an educated guess why PH would want to do that, but they better be careful if they have an obligation to report trades - NIA
Eyesblue, that large trade was a fill, the flip side of a purchase at the offer price, which, had it of been printed, would have been the largest purchase printed this year... alas as others have noted, only the sell side (presumably peel hunt filling) is being printed, giving the impression of constant sells. If PH have shed loads, as per RNS then not quite sure why they would want to exclude buys, as price likely to rise, indeed I think all trades are supposed to be printed anyway.... but if there is value in GLR it will come out eventually. Good news from CB’s ramblings, guaranteed offtake for SZ, even though he is gunning after Kashito drilling, let’s hope the raising is enough to get the drill done, or JORC on SZ, or by some miracle they do sell Glenover or JV Nevada to bring in cash. I was pleasantly surprised to see his non-exec present at the presentation, the same money man who created the shell GLR reversesld into originally, and the same CB/RW partnership that reversed Kiawara prior to the coup of CB’s career with the sale to First Quantum - someone still has faith and with CB holding millions of shares, we might see some progress - NIA and DYOR - Good Luck
Hi - no, i’m not saying that, I think based on the credibility and track record of 4 of the other shells from the same director and stakeholder here, that this may also come good at some point.... then secondly that few PI’s do much deep research at all, which is why no one so far has made the link between any of the six, over 10+ years on this board, to my knowledge and hence why the 6th is not receiving much attention, so I won’t mention the company.... from a PI perspective, each to their own, best of luck and happy Christmas to all
No probs UKChips, mostly no-one is listening to sensible research... there is a 6th shell, from the same tried and trusted route, again listed UK market. Number of posts on it's board = Zero, number of irrelevant posts on this one = 14.7 million, I won't even mention the name, NIA...
all public info here, if you take Blueface’s advice and research Colin, you’ll realise before he sold Kiawara to first quantum, kiawara was a reversal of Wadharma, previously celltalk, previously a cash shell brought to market by Richard, a significant shareholder here in Galileo. Anyone in the that shell from inception would have seen strong returns. That shell was the 3rd bought to market, Galileo here is the 5th, Immupharma (4th) has recently achieved many multiples... the earlier shells BDA-Edge, Grantchester, Hacas-tribal also many multiples of share price growth, not to mention CDFF which has risen from 50p to over £16.00 over a long period of time, still going. It’s not Colin I followed here, it’s his colleague with the financial expertise.... who knows if this will come good,, but i’m prepared to put money into finding out in the long run. No advice intended and DYOR - Joe
Well, this small cap is below the lowest of radars, i believe this is the 6th shell brought to market, first two (in this sector) wildly successful, 3rd eventually also v successful, 4th and 5th still in play... With many common names, I expect they will eventually come right.... GNI only ever upward trend, reversed into Altair a few months ago, already completed next acquisition since, more to come perhaps - good luck to those v few investors in this one